期刊文献+

大鼠骨髓间充质干细胞促进肝星状细胞凋亡的机制研究 被引量:2

Mechanism of bone marrow-derived mesenchymal stem cell-promoted apoptosis of hepatic stellate cells
原文传递
导出
摘要 目的探讨大鼠骨髓间充质干细胞(BMSC)与肝星状细胞(HSC)共培养体系中BMSC旁分泌肝细胞生长因子(HGF)对HSC凋亡的影响及其机制。方法用半透膜建立上下双层细胞共培养体系,各组培养24、48、72h,倒置相差显微镜观察细胞形态学变化,免疫细胞化学法观察α-肌动蛋白(仅-SMA)表达情况;四甲基偶氮唑盐法检测Y-27632及PHA665752的最佳干预浓度l流式细胞仪检测HSC凋亡率lWesternNot、实时荧光定量PCR检测肝星状细胞RhoAmRNA及蛋白表达情况;酶联免疫吸附法检测HGF及肝细胞生长因子激活因子(HGFA)浓度。计量资料采用单因素方差分析,P〈0.05为差异有统计学意义。结果随着时间的延长,HSC凋亡率逐渐增高,实验b组凋亡率最低,实验c组凋亡率最高,均以72h最为显著,各组在各时段凋亡率差异具有统计学意义(P〈0.05);实验C组RhoA蛋白及mRNA表达量较其他各组明显下降,差异有统计学意义(P〈0.05);各组RhoA蛋白及mRNA表达量随时间的延长而逐渐增加;实验各组HGF浓度随时间延长逐渐降低,实验b、c组较对照组增高,差异有统计学意义(P〈0.05);实验各组HGFA浓度随时间延长逐渐增高,实验b组升高最为明显,差异有统计学意义(P〈0.01)。结论BMSC通过激活HGF并下调Rho通路促进肝星状细胞凋亡。 Objective To explore the role of the Rho pathway in the hepatocyte growth factor (HGF) paracrine signal-mediated bone marrow-derived mesenchymal stem cell (BMSC) promotion of apoptosis of hepatic stellate cells (HSCs). Methods A BMSC-HSC co-culture system was established using plates with transwell inserts. Dynamic changes in response to pretreatment with the c-met blocker PHA665752 and the Rho pathway inhibitor Y-27632 were observed under an inverted phase contrast microscope at 24, 48 and 72 h of culture. Optimal intervention concentrations of Y-27632 and PHA665752 were determined by MTT assay. Expression of alpha-smooth muscle actin in HSCs was evaluated by immunohistochemistry, and the apoptosis rate of HSCs was measured by Annexin- V-FITC/propidium iodide. RhoA protein and mRNA levels were measured by western blot and quantitative real-time PCR respectively. Concentrations of HGF and hepatocyte growth factor activator (HGFA) were quantified by enzyme-linked immunosorbent assay. Between-group differences were evaluated by one-way ANOVA with P 〈 0.05 indicating significance. ResuRs The apoptosis rates ofHSCs gradually and steadily increased in a time-dependent manner. The apoptosis rate of the PHA665752 pretreated group was lowest and that of the Y-27632 pretreated group was highest, with the most robust difference occurring at the 72 h time point (P 〈 0.05). The mRNA and protein expression levels of RhoA decreased in a time-dependent manner in the Y-27632 pretreated group (all time points, P 〈 0.05) but the expression levels increased in a time-dependent manner in the PHA665752 pretreated group (all time points, P 〈 0.05). For both the PHA665752 and the Y-27632 pretreated groups, the concentration of HGF decreased in a time-dependent manner, but the concentrations in both remained significantly higher than that in the control group at all time points examined (P 〈 0.05). The concentration of HGFA increased ha a time-dependent manner, and the PHA665752 pretreated group showed significantly higher levels than any of the other groups at aU time points examined (P 〈 0.01). Conclusion BMSC promotes HSC apoptosis in a co-culture system by activating HGF and down-remalatine the RhoA signaling pathwav.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2014年第3期223-227,共5页 Chinese Journal of Hepatology
基金 国家自然科学基金(81260083),广西自然科学基金(03201212030),广西卫生厅自筹经费科研(Z2009102)
关键词 肝细胞生长因子 肝细胞生长因子激活因子 肝星状细胞 骨髓间充质干 细胞 Hepatocyte growth factor Hepatoeyte growth factor activator Hepatic stellate ceils Bone marrow mesenchymal stem cells
  • 相关文献

参考文献2

二级参考文献16

  • 1高春芳,孔宪涛,范列英.大鼠肝贮脂细胞、Kupffer细胞的分离、培养和鉴定[J].中华消化杂志,1995,15(3):142-145. 被引量:12
  • 2Knook DL,Seffelaar AM,de Leeuw AM.Fat-storing cells of the rat liver.Their isolation and purification[J].Exp Cell Res,1982,139(2):468-471.
  • 3Zhang G,Tan N,Liang LX,et al.Smad7 attenuate inducible collagen production in hepatic stellate cells involving the regulation of P21 and P27[J].FASEB J,2008,22(4):F242.
  • 4Friedman SL,Roll FJ.Isolation and culture of hepatic lipocytes,Kupffer cells,and sinusoidal endothelial cells by density gradient centfifugation with Stractan[J].Anal Biochem,1987,161(1):207-218.
  • 5徐列明,刘成,刘平.扁桃甙对大鼠肝贮脂细胞增殖和产生胶原的影响[J].新消化病学杂志,1997,5(2):84-85. 被引量:27
  • 6Kharaziha P, Hellstrom PM, Noorinayer B, et al.. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol, 2009, 21: 1199-1205.
  • 7Nakamura T, Sakai K, Nakamura T, et al. Hepatocyte growth factor twenty years on: Much more than a growth factor. J Gastroenterol Hepatol, 2011, 26:188-202.
  • 8Shi L, Li G, Wang J, et al. Bone marrow stromal cells control the growth of hepatic stellate cells in vitro. Dig Dis Sci, 2008, 53: 2969- 2974.
  • 9Wang J, Bian C, Liao L, et al. Inhibition of hepatic stellate cells proliferation by mesenchymal stem cells and the possible mechanisms. Hepatol Res, 2009, 39: 1219-1228.
  • 10Miyazawa K, Shimomura T. Proteolytic cascade for activation of hepatocyte growth factor in response to tissue injury. Seikagaku, 1995, 67: 381-385.

共引文献8

同被引文献10

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部